# Assessment of Beta Cell Mass by PET Scans With [11C] Dihydrotetrabenazine (DTBZ) in Longstanding Type 1 Diabetes.

> **NCT00738907** · — · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 18 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00738907
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-01
- **Final completion:** 2008-05
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2014-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00738907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00738907, "Assessment of Beta Cell Mass by PET Scans With [11C] Dihydrotetrabenazine (DTBZ) in Longstanding Type 1 Diabetes.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00738907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*